Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway

INTRODUCTION: Cell-based therapy represents a new frontier in the treatment of a wide variety of human diseases traditionally associated with morbidity outcomes, including those involving inflammation, autoimmunity, tissue damage, and cancer. However, the use of mesenchymal stem cells (MSCs) to trea...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Atsuta, Ikiru, Liu, Shiyu, Miura, Yasuo, Akiyama, Kentaro, Chen, Chider, An, Ying, Shi, Songtao, Chen, Fa-Ming
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854680/
https://ncbi.nlm.nih.gov/pubmed/24025590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/scrt322
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller